L

LivaNova PLC

LIVN

48.270
USD
-1.13
(-2.29%)
Market Closed
Volume
5,267
EPS
0
Div Yield
0
P/E
-172
Market Cap
2,895,167,227
Related Instruments
ABT
4.220
(3.98%)
110.150 USD
B
BAX
0.190
(0.53%)
36.000 USD
BDX
-4.995
(-2.07%)
236.055 USD
BSX
1.315
(1.78%)
75.170 USD
EW
-1.220
(-1.94%)
61.830 USD
H
HOLX
1.610
(1.97%)
83.220 USD
ISRG
6.98
(1.57%)
451.27 USD
MCK
11.85
(1.92%)
628.90 USD
T
TFX
14.900
(6.74%)
236.060 USD
TMO
9.03
(1.47%)
621.78 USD
News

Title: LivaNova PLC

Sector: Healthcare
Industry: Medical Devices
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.